Research Article
Expression of the JAK/STAT Signaling Pathway in Bullous Pemphigoid and Dermatitis Herpetiformis
Figure 4
Immunoexpression of JAK/STAT proteins in epidermis, BP, 400x, immunohistochemistry. Immunoexpression of JAK3 in epidermis (a) perilesional skin 12.54 ± 2.99 and (e) skin lesions 18.19 ± 5.58, ; immunoexpression of STAT2 in epidermis (b) perilesional skin 14.01 ± 2.38 and (f) skin lesions 17.32 ± 2.69, ; immunoexpression of STAT4 in epidermis (c) perilesional skin 21.05 ± 2.91 and (g) skin lesions 25.13 ± 3.56, NS; immunoexpression of STAT6 in epidermis (d) perilesional skin 17.46 ± 2.41 and (h) skin lesions 26.09 ± 4.45, NS.
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |